CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 172 filers reported holding CARA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $15,021 | +12.0% | 16,507 | -8.5% | 0.00% | – |
| Q4 2023 | $13,408 | -58.7% | 18,046 | -6.6% | 0.00% | – |
| Q3 2023 | $32,471 | -35.9% | 19,328 | +8.0% | 0.00% | – |
| Q2 2023 | $50,657 | -96.3% | 17,900 | -93.6% | 0.00% | -100.0% |
| Q1 2023 | $1,379,081 | -54.9% | 280,872 | -1.3% | 0.00% | -50.0% |
| Q4 2022 | $3,057,227 | +11.0% | 284,658 | -3.3% | 0.00% | 0.0% |
| Q3 2022 | $2,754,000 | +2.1% | 294,284 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $2,697,000 | -39.4% | 295,414 | -19.3% | 0.00% | -33.3% |
| Q1 2022 | $4,447,000 | -11.7% | 365,982 | -11.5% | 0.00% | 0.0% |
| Q4 2021 | $5,038,000 | -7.6% | 413,618 | +17.2% | 0.00% | -25.0% |
| Q3 2021 | $5,454,000 | +4.4% | 353,037 | -3.5% | 0.00% | +33.3% |
| Q2 2021 | $5,222,000 | +2210.6% | 365,953 | +3413.4% | 0.00% | – |
| Q1 2021 | $226,000 | +43.0% | 10,416 | -0.1% | 0.00% | – |
| Q4 2020 | $158,000 | – | 10,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,647,473 | $24,780,000 | 2.96% |
| Chescapmanager LLC | 1,160,392 | $10,861,000 | 2.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,333,000 | $12,477,000 | 1.60% |
| Altium Capital Management LP | 193,000 | $1,806,000 | 0.66% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,700,230 | $15,914,000 | 0.44% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 171,423 | $1,605,000 | 0.22% |
| Lisanti Capital Growth, LLC | 159,225 | $1,490,000 | 0.20% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 72,529 | $679,000 | 0.15% |
| PINNACLE ASSOCIATES LTD | 705,367 | $6,602,000 | 0.15% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $23,400,000 | 0.13% |